ADAP - Adaptimmune GAAP EPS of -$0.04 beats by $0.22 revenue of $7M beats by $2.03M
- Adaptimmune press release ( NASDAQ: ADAP ): Q3 GAAP EPS of -$0.04 beats by $0.22 .
- Revenue of $7M (+483.3% Y/Y) beats by $2.03M .
- The Company is deprioritizing non-core programs and is also undertaking a restructuring of the Company including a headcount reduction of approximately 25% to 30% with the aim of extending its cash runway into early 2025.
For further details see:
Adaptimmune GAAP EPS of -$0.04 beats by $0.22, revenue of $7M beats by $2.03M